Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

15.33 

0.00 0.0%

as of Sep 30 '22

52 Week Range:

15.33 17.50


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Sekisui Chemical Co., Ltd. engages in housing, urban infrastructure and environmental products (UIEP), high-performance plastics (HPP), and medical businesses. The Housing segment engages in the manufacturing, construction, sale, refurbishing, and other operations related to unit housing, real estate, and residential service business. The UIEP segment manufactures, constructs, and sells PVC pipes and joints, polyethylene pipes and joints, pipe and drain renewal materials and construction methods, reinforced plastic pipe, construction materials, and fiber-reinforced foamed urethane. The HPP segment engages in the manufacture and sale of interlayer films for laminated glass, polyolefin foam, tape, LCD fine particles and photosensitive materials, functional resin for infrastructure, diagnostic drugs, and other products. The Medical segment manufactures and sells diagnostic reagents, analyzers, pharmaceutical ingredients, and intermediates. It operates in Japan, the United States, Europe, Asia, and internationally. The company was formerly known as Sekisui Sangyo Co., Ltd. and changed its name to Sekisui Chemical Co., Ltd. in 1948. Sekisui Chemical Co., Ltd. was incorporated in 1947 and is headquartered in Osaka, Japan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Equity (BVPS) 8.36
11.30
growth rate 7.8%
Earnings BIT 85,765.00
89,823.00
96,478.00
99,233.00
95,688.00
87,770.00
67,302.00
88,880.00
growth rate 4.7% 7.4% 2.9% -3.6% -8.3% -23.3% 32.1%
Avg.PE 2.24
2.21
2.21
93.74
93.74
93.74
93.74
93.74
growth rate -1.3% 0.0% 4,141.6% 0.0% 0.0% 0.0% 0.0%
ROA 3.48
3.49
4.42
5.49
5.95
6.47
6.53
6.53
5.54
3.69
growth rate 0.3% 26.7% 24.2% 8.4% 8.7% 0.9% 0.0% -15.2% -33.4%
ROE 8.12
7.83
9.40
10.88
10.89
11.34
11.15
11.06
9.69
6.51
growth rate -3.6% 20.1% 15.7% 0.1% 4.1% -1.7% -0.8% -12.4% -32.8%
ROIC 6.14
6.14
7.76
9.43
9.84
10.39
10.29
10.14
8.46
5.46
growth rate 0.0% 26.4% 21.5% 4.4% 5.6% -1.0% -1.5% -16.6% -35.5%
Cur. Ratio 1.24
1.31
1.27
1.40
1.38
1.61
1.58
1.51
1.47
1.79
growth rate 5.7% -3.1% 10.2% -1.4% 16.7% -1.9% -4.4% -2.7% 21.8%
Quick Ratio 0.72
0.79
0.77
0.83
0.78
0.96
0.90
0.83
0.76
0.91
growth rate 9.7% -2.5% 7.8% -6.0% 23.1% -6.3% -7.8% -8.4% 19.7%
Leverage 2.35
2.15
2.10
1.87
1.79
1.72
1.70
1.69
1.80
1.72
growth rate -8.5% -2.3% -11.0% -4.3% -3.9% -1.2% -0.6% 6.5% -4.4%
Balance Sheet Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Acct.Receivable 185,263.00
175,272.00
168,020.00
188,896.00
187,674.00
174,213.00
169,461.00
184,672.00
growth rate -5.4% -4.1% 12.4% -0.7% -7.2% -2.7% 9.0%
Acct.Payable 135,971.00
125,034.00
120,120.00
130,819.00
130,440.00
131,775.00
117,594.00
138,181.00
growth rate -8.0% -3.9% 8.9% -0.3% 1.0% -10.8% 17.5%
Cur.Assets 466,164.00
434,513.00
466,101.00
473,297.00
470,037.00
491,883.00
505,571.00
609,395.00
growth rate -6.8% 7.3% 1.5% -0.7% 4.7% 2.8% 20.5%
Total Assets 968,011.00
936,043.00
943,640.00
999,114.00
1,023,706.00
1,102,352.00
1,150,143.00
1,198,921.00
growth rate -3.3% 0.8% 5.9% 2.5% 7.7% 4.3% 4.2%
Cash 87,169.00
68,007.00
109,891.00
77,996.00
69,882.00
76,819.00
87,454.00
144,534.00
growth rate -22.0% 61.6% -29.0% -10.4% 9.9% 13.8% 65.3%
Inventory 157,603.00
150,759.00
153,551.00
170,457.00
192,187.00
217,189.00
222,909.00
243,837.00
growth rate -4.3% 1.9% 11.0% 12.8% 13.0% 2.6% 9.4%
Cur.Liabilities 333,426.00
314,944.00
290,081.00
299,050.00
311,180.00
334,212.00
282,278.00
329,694.00
growth rate -5.5% -7.9% 3.1% 4.1% 7.4% -15.5% 16.8%
Liabilities 432,720.00
391,889.00
373,092.00
386,358.00
390,962.00
468,079.00
455,752.00
496,170.00
growth rate -9.4% -4.8% 3.6% 1.2% 19.7% -2.6% 8.9%
LT Debt 27,111.00
9,638.00
20,043.00
18,002.00
18,622.00
62,368.00
111,207.00
98,093.00
growth rate -64.5% 108.0% -10.2% 3.4% 234.9% 78.3% -11.8%
Equity 516,725.00
523,568.00
549,761.00
588,036.00
607,279.00
609,372.00
667,066.00
674,635.00
growth rate 1.3% 5.0% 7.0% 3.3% 0.3% 9.5% 1.1%
Common Shares 521.00
516.00
515.00
507.00
493.00
483.00
475.00
100,002.00
100,002.00
100,002.00
100,002.00
growth rate -1.0% -0.2% -1.6% -2.8% -2.0% -1.7% 20,953.1% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Capital Expenditures 34,602.00
39,444.00
35,241.00
45,526.00
60,082.00
52,683.00
55,359.00
36,997.00
growth rate 14.0% -10.7% 29.2% 32.0% -12.3% 5.1% -33.2%
Cash Dividends 12,743.00
13,820.00
15,538.00
18,134.00
19,706.00
21,286.00
20,952.00
21,532.00
growth rate 8.5% 12.4% 16.7% 8.7% 8.0% -1.6% 2.8%
Cash From OA 67,760.00
71,389.00
108,229.00
82,272.00
85,213.00
92,647.00
75,271.00
105,023.00
growth rate 5.4% 51.6% -24.0% 3.6% 8.7% -18.8% 39.5%
FCF per Share 0.40
0.48
growth rate 4.7%
FCF 38,266.00
38,965.00
65,798.00
27,641.00
26,257.00
68,416.00
32,535.00
19,020.00
35,420.00
13,204.00
68,026.00
growth rate 1.8% 68.9% -58.0% -5.0% 160.6% -52.5% -41.5% 86.2% -62.7% 415.2%
Income Statement Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Sales 1,112,748.00
1,096,317.00
1,065,776.00
1,107,429.00
1,142,713.00
1,129,254.00
1,056,560.00
1,157,945.00
growth rate -1.5% -2.8% 3.9% 3.2% -1.2% -6.4% 9.6%
Op.Income 85,765.00
89,823.00
96,478.00
99,233.00
95,688.00
87,770.00
67,302.00
88,880.00
growth rate 4.7% 7.4% 2.9% -3.6% -8.3% -23.3% 32.1%
IBT 84,231.00
77,949.00
82,850.00
94,341.00
93,907.00
83,580.00
63,179.00
69,857.00
growth rate -7.5% 6.3% 13.9% -0.5% -11.0% -24.4% 10.6%
Net Income 52,995.00
56,653.00
60,850.00
63,459.00
66,093.00
58,931.00
41,544.00
37,067.00
growth rate 6.9% 7.4% 4.3% 4.2% -10.8% -29.5% -10.8%
EPS 53.94
58.50
79.94
104.55
114.88
125.95
133.58
141.64
128.77
91.92
growth rate 8.5% 36.7% 30.8% 9.9% 9.6% 6.1% 6.0% -9.1% -28.6%
Gross Profit 337,618.00
345,804.00
353,518.00
362,083.00
368,066.00
362,703.00
330,386.00
355,951.00
growth rate 2.4% 2.2% 2.4% 1.7% -1.5% -8.9% 7.7%
R&D 29,452.00
31,693.00
34,169.00
36,974.00
38,838.00
37,146.00
35,110.00
37,010.00
growth rate 7.6% 7.8% 8.2% 5.0% -4.4% -5.5% 5.4%

Quarterly Statements

Item Name Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Earnings BIT 11,122.00
24,399.00
21,934.00
31,425.00
13,845.00
growth rate 119.4% -10.1% 43.3% -55.9%
Balance Sheet Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Acct.Receivable 153,673.00
156,223.00
176,870.00
184,672.00
177,208.00
growth rate 1.7% 13.2% 4.4% -4.0%
Acct.Payable 112,861.00
118,208.00
129,251.00
138,181.00
106,947.00
growth rate 4.7% 9.3% 6.9% -22.6%
Cur.Assets 507,448.00
560,878.00
574,109.00
609,395.00
595,577.00
growth rate 10.5% 2.4% 6.2% -2.3%
Total Assets 1,137,952.00
1,120,775.00
1,135,237.00
1,198,921.00
1,200,380.00
growth rate -1.5% 1.3% 5.6% 0.1%
Cash 84,331.00
136,087.00
116,936.00
144,534.00
96,148.00
growth rate 61.4% -14.1% 23.6% -33.5%
Inventory 239,056.00
233,783.00
244,930.00
243,837.00
269,860.00
growth rate -2.2% 4.8% -0.5% 10.7%
Cur.Liabilities 282,781.00
300,193.00
316,185.00
329,694.00
326,822.00
growth rate 6.2% 5.3% 4.3% -0.9%
Liabilities 452,211.00
463,628.00
467,390.00
496,170.00
493,249.00
growth rate 2.5% 0.8% 6.2% -0.6%
LT Debt 111,055.00
110,060.00
98,598.00
98,093.00
97,152.00
growth rate -0.9% -10.4% -0.5% -1.0%
Equity 658,441.00
630,899.00
640,817.00
674,635.00
679,463.00
growth rate -4.2% 1.6% 5.3% 0.7%
Common Shares 100,002.00
100,002.00
100,002.00
100,002.00
100,002.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Capital Expenditures 8,194.00
8,588.00
9,149.00
11,066.00
7,890.00
growth rate 4.8% 6.5% 21.0% -28.7%
Cash Dividends 10,805.00
10,735.00
10,735.00
11,130.00
11,130.00
growth rate -0.7% 0.0% 3.7% 0.0%
Cash From OA 11,336.00
44,889.00
9,506.00
39,292.00
-2,131.00
growth rate 296.0% -78.8% 313.3% -100.0%
FCF 3,142.00
36,301.00
357.00
28,226.00
-10,021.00
growth rate 1,055.4% -99.0% 7,806.4% -100.0%
Income Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Sales 248,596.00
299,346.00
290,709.00
319,294.00
282,271.00
growth rate 20.4% -2.9% 9.8% -11.6%
Op.Income 11,122.00
24,399.00
21,934.00
31,425.00
13,845.00
growth rate 119.4% -10.1% 43.3% -55.9%
IBT 18,986.00
-6,573.00
25,158.00
32,286.00
20,910.00
growth rate -100.0% 100.0% 28.3% -35.2%
Net Income 12,533.00
-16,447.00
16,648.00
24,333.00
14,578.00
growth rate -100.0% 100.0% 46.2% -40.1%
Gross Profit 77,938.00
92,011.00
89,844.00
96,158.00
84,542.00
growth rate 18.1% -2.4% 7.0% -12.1%
R&D 37,010.00
37,010.00
37,010.00
growth rate 0.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (32.60)

YOY Growth Grade:

E (28.68)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 18.21 18.21
EPS / Growth 0.84

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 3.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 3.7% 3.7% 3.7%
Future PE 0.01 8.53 8.53
Future EPS 1.21 1.21 1.21
Value Price
MOS %
0.00
-100.0%
2.55
-83.4%
2.55
-83.4%
MOS Price 0.00 1.27 1.27
IRT 13.79 13.79 13.79

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.